244 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MYL Mylan N.V. $37.22 $19.19B N/A
Article Searches
Teva Settles With Oklahoma, Shares Fall Following Downgrade http://www.zacks.com/stock/news/421544/teva-settles-with-oklahoma-shares-fall-following-downgrade?cid=CS-ZC-FT-421544 May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
Company News For May 8, 2019 http://www.zacks.com/stock/news/410963/company-news-for-may-8-2019?cid=CS-ZC--410963 May 08, 2019 - Companies In The News Are: MYL,AIG,ARMK,ATKR
Mylan N.V. (MYL) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/07/mylan-nv-myl-q1-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 May 07, 2019 - MYL earnings call for the period ending March 31, 2019.
Mylan N.V. (MYL) CEO Heather Bresch on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4261110-mylan-n-v-myl-ceo-heather-bresch-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 07, 2019 - Mylan N.V. (NASDAQ:MYL) Q1 2019 Results Earnings Conference Call May 07, 2019, 10:00 AM ET Company Participants Melissa Trombetta - Head, Global Investor Relations Heather Bresch - CEO Rajiv Malik - P
Mylan's (MYL) Q1 Earnings Beat Estimates, Revenues Miss http://www.zacks.com/stock/news/410473/mylans-myl-q1-earnings-beat-estimates-revenues-miss?cid=CS-ZC-FT-410473 May 07, 2019 - Mylan's (MYL) earnings beat estimates but sales miss the same in the first quarter of 2019.
MYL, GLUU, SEDG and CRAY among midday movers https://seekingalpha.com/news/3460027-myl-gluu-sedg-cray-among-midday-movers?source=feed_news_all May 07, 2019 - Gainers: Bridgeline Digital (NASDAQ:BLIN) +30%. Cohu (NASDAQ:COHU) +27%. ATA (NASDAQ:ATAI) +25%. ARCA biopharma (NASDAQ:ABIO) +24%. SolarEdge Technologies (NASDAQ:SEDG) +23%. Summit Wireless Technolog
Acorda (ACOR) Earnings and Revenues Beat Estimates in Q1 http://www.zacks.com/stock/news/408005/acorda-acor-earnings-and-revenues-beat-estimates-in-q1?cid=CS-ZC-FT-408005 May 02, 2019 - Acorda's (ACOR) shares rise on earnings and revenue beat in Q1. Inbrija registers first sales figure following its launch in the reported quarter.
Teva (TEVA) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/405122/teva-teva-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-405122 Apr 29, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Teva's (TEVA) sales in Q1.
Acorda to Gain From Inbrija Sales and Neurological Pipeline http://www.zacks.com/stock/news/379221/acorda-to-gain-from-inbrija-sales-and-neurological-pipeline?cid=CS-ZC-FT-379221 Apr 11, 2019 - Acorda (ACOR) aims to boost sales with the launch of its newly FDA-approved Parkinson's disease drug, Inbrija. The company's pipeline looks promising as well.
Falling Earnings Estimates Signal Weakness Ahead for Mylan (MYL) http://www.zacks.com/stock/news/365966/falling-earnings-estimates-signal-weakness-ahead-for-mylan-myl?cid=CS-ZC-FT-365966 Mar 28, 2019 - Mylan (MYL) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.

Pages: 123456...25

Page 1>